INNOPHARMA

REACT-EU PROJECT
CONVENIO DE COLABORACIÓN ENTRE A AXENCIA GALEGA DE INNOVACIÓN E A UNIVERSIDADE DE SANTIAGO DE COMPOSTELA PARA REGULAR AS CONDICIÓNS DA AXUDA DESTINADA Á ACTUALIZACIÓN E AMPLIACIÓN DA PLATAFORMA INNOPHARMA DA USC
Click for more Info

The INNOPHARMA Drug Screening and Pharmacogenomics Platform arises from the BioFarma group's accumulated experience of more than 20 years in continuing programs, testing hundreds of thousands of compounds, tens of targets and the development, automation and implementation of hundreds of assays in complete cascades of early drug discovery.

The high-capacity infrastructures owned by INNOPHARMA allow it to be a European reference in early drug discovery, being accredited as one of the seven high-capacity nodes of the European Research Infrastructure Consortium (ERIC) EU-OPENSCREEN. INNOPHARMA Platform offers a set of services that cover all stages of the early drug discovery process from target identification to preliminary safety and toxicity assessment.

The platform is available for both on-demand services and complementary collaborative projects in drug discovery.